SEMAX
$29.99A synthetic heptapeptide analog of ACTH (4-7), developed by the Institute of Molecular Genetics in Russia. Research has investigated its neuroprotective, nootropic, and neurotrophic properties, including BDNF upregulation, dopaminergic and serotonergic system modulation, and improved cognitive performance in preclinical models. Studied for applications in ischemic stroke recovery and attention/memory enhancement. For research use only.

